中国医学装备
中國醫學裝備
중국의학장비
CHINA MEDICAL EQUIPMENT
2015年
1期
96-98,99
,共4页
ICU优化治疗%心脏骤停后综合征%脑复苏%临床疗效
ICU優化治療%心髒驟停後綜閤徵%腦複囌%臨床療效
ICU우화치료%심장취정후종합정%뇌복소%림상료효
ICU optimize treatment%Post-cardiac arrest syndrome%Cerebral resuscitation%Clinical efficacy
目的：探讨重症监护病房(ICU)优化治疗对心脏骤停后综合征(PCAS)患者脑复苏的临床疗效。方法：将在ICU治疗的92例心脏骤停并成功复苏患者采用随机方式将其分为对照组和观察组，每组46例。对照组采取院内ICU常规治疗措施；观察组采用院内ICU优化治疗方式；对两组患者在治疗中的神经功能情况、并发症及病死率进行对比分析。结果：两组患者机械通气时间及停留时间比较无显著差异；观察组患者神经功能恢复占45.7%，明显优于对照组的21.7%；病死率为45.7%明显低于对照组的73.9%，两组相比其差异有统计学意义(x2=3.84，P＜0.05)；两组在并发症方面比较无显著差异。结论：ICU优化治疗能明显改善心脏骤停后综合征患者的神经功能，并能够有效降低患者病死率，值得进一步推广应用。
目的：探討重癥鑑護病房(ICU)優化治療對心髒驟停後綜閤徵(PCAS)患者腦複囌的臨床療效。方法：將在ICU治療的92例心髒驟停併成功複囌患者採用隨機方式將其分為對照組和觀察組，每組46例。對照組採取院內ICU常規治療措施；觀察組採用院內ICU優化治療方式；對兩組患者在治療中的神經功能情況、併髮癥及病死率進行對比分析。結果：兩組患者機械通氣時間及停留時間比較無顯著差異；觀察組患者神經功能恢複佔45.7%，明顯優于對照組的21.7%；病死率為45.7%明顯低于對照組的73.9%，兩組相比其差異有統計學意義(x2=3.84，P＜0.05)；兩組在併髮癥方麵比較無顯著差異。結論：ICU優化治療能明顯改善心髒驟停後綜閤徵患者的神經功能，併能夠有效降低患者病死率，值得進一步推廣應用。
목적：탐토중증감호병방(ICU)우화치료대심장취정후종합정(PCAS)환자뇌복소적림상료효。방법：장재ICU치료적92례심장취정병성공복소환자채용수궤방식장기분위대조조화관찰조，매조46례。대조조채취원내ICU상규치료조시；관찰조채용원내ICU우화치료방식；대량조환자재치료중적신경공능정황、병발증급병사솔진행대비분석。결과：량조환자궤계통기시간급정류시간비교무현저차이；관찰조환자신경공능회복점45.7%，명현우우대조조적21.7%；병사솔위45.7%명현저우대조조적73.9%，량조상비기차이유통계학의의(x2=3.84，P＜0.05)；량조재병발증방면비교무현저차이。결론：ICU우화치료능명현개선심장취정후종합정환자적신경공능，병능구유효강저환자병사솔，치득진일보추엄응용。
Objective: To investigate the optimal therapy for ICU post-cardiac arrest syndrome (PCAS) clinical efficacy in patients with cerebral resuscitation. Methods: In our hospital intensive care unit (ICU) treatment of cardiac arrest and the successful recovery of the 92 patients ,using randomly divided into control group and observation group of 46 cases, in which the control group taking conventional treatment hospital ICU, observation group hospital ICU optimize treatment , two groups of patients in the ICU treatment period nerve function, complications and mortality rates were analyzed. Results:The patients in the ICU and duration of mechanical ventilation was no significant difference, but a good neurological outcomes observed group of patients , 45.7%, significantly better than the control group, 21.7% , and the mortality rate was 45.7%, 73.9%, significantly lower than the control group , the difference was statistically significant (x2=3.84, P<0.05);complications compared in the two groups showed no significant difference. Conclusion: ICU optimize treatment can significantly improve cardiac arrest syndrome nerve function , and can effectively reduce mortality , worthy of further application.
